RELEUKO FDA approval date

The FDA approved RELEUKO on 25 Feb 2022.

FDA approval date
25 Feb 2022

Drug identity has not yet been verified against registry records

Also recorded as FILGRASTIM-AYOW

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-02-25DayRELEUKOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761082", "applicant_as_listed_by_fda": "KASHIV BIOSCIENCES LLC", "brand_names": ["RELEUKO"], "active_ingredients": ["FILGRASTIM-AYOW"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220225", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026